ARHGEF12 and neoplasm: The application of L-ARG deprivation has been optimized using polyethylene glycol (PEG) technology to diminish immunogenicity, increase bioavailability, and selectively degrade arginine, therefore resulting in tumour cell death (Feun et al., 2008).